BRIC Diabetes Care Devices Market Analysis, Size, Growth, Share, Trend, Outlook & Forecast to 2026
The BRIC diabetes care devices market size is projected to reach USD 4.82 million by 2026, according to a new report by Grand View Research, Inc. It is anticipated to register a 5.28% CAGR over the forecast period. The market in BRIC nations is primarily driven by the increasing prevalence of diabetes, especially among geriatric and obese population. Increasing collaboration and funding support to research is further augmenting the growth. The factors responsible for the increasing incidence of glucose impairment are the increasing alcohol and tobacco consumption, lack of physical activity, and obesity. However, increasing prices of advanced devices and presence of cost-effective alternative treatment may restrict the market growth. BRIC nations are also witnessing large untapped opportunities with favorable government initiatives focused on disease awareness. According to the World Health Organization (WHO), more than 50% Indian population with diabetes remains undiagnosed. Many government initiatives and approval from the Food and Drug Administration (FDA) for advanced diabetes care devices are also propelling the growth. For instance, in 2019, the Research Trust of Diabetes India launched its 1000 days Initiative to control diabetes in the country. This initiative will bring together diabetologists across India to provide recommendations and clinical guidelines. Furthermore, technological advancements coupled with collaboration among key market players is also propelling the market growth. For
instance, in September 2019, Abbott and Sanofi collaborated to work on tools that integrate Sanofi’s insulin dosing information with Abbott’s FreeStyle Libre technology. Browse Details of Report @ https://www.grandviewresearch.com/industry-analysis/bric-diabetescare-devices-market BRIC Diabetes Care Devices Market Report Highlights
Based on product, the insulin delivery devices dominated with over 60% market share in 2018. Insulin Pumps segment is expected to register the fastest CAGR of 3.81% during the forecast period owing to increasing number of patients with glucose impairments and availability of ease to use and convenient pumps
On the basis of CGM devices, sensors dominated the segment with a revenue of over 100 million in 2018, attributed to high usage and adoption of these devices
China held the dominant market position in 2018 and is expected to retain its lead throughout the forecast period. Large diabetes population and supportive government initiatives are the key factors driving market growth in the country
Some of the prominent players in the BRIC diabetes care devices market include Johnson & Johnson; Ypsomed AG; Bayer AG; F. Hoffmann-La Roche Ltd; Abbott Laboratories; Becton, Dickinson and Company; Medtronic Plc; Ypsomed AG; Sanofi; Novo Nordisk A/S; Arkray, Inc.; Acon Laboratories, Inc.; Terumo Corporation; and Dexcom, Inc.
BRIC Diabetes Care Devices Market Segmentation Grand View Research has segmented BRIC diabetes care devices market on the basis of product, and region: BRIC Diabetes Care Devices Product Outlook (Revenue, USD Million, 2015 - 2026) Blood Glucose Monitoring Devices o
Self-monitoring Devices o Blood Glucose Meter o Testing Strips o Lancets
o
Continuous Glucose Monitoring Devices o Sensors o Transmitter o Receiver
Insulin Delivery Devices o
Pens
o
Pumps
o
Syringes
o
Jet Injectors
What questions do you have Get quick response from our industry experts @ https://www.grandviewresearch.com/request-free-consultation/6861/rfc
BRIC Diabetes Care Devices Regional Outlook (Revenue, USD Million, 2015 - 2026) BRIC o
Brazil
o
Russia
o
India
o
China
Table of Contents Chapter 1 Methodology and Scope 1.1 Market Segmentation and Scope 1.1.1 Product 1.1.2 Mode of delivery 1.1.3 Application 1.1.4 regional scope 1.1.5 Estimates and forecast timeline 1.2 Research Methodology 1.3 Information procurement 1.3.1 Purchased database: 1.3.2 GVR’s internal database 1.3.3 Secondary sources 1.3.4 Primary research 1.3.5 Details of primary research 1.3.5.1 Data for primary interviews in North america 1.3.5.2 Data for primary interviews in Europe
1.3.5.3 Data for primary interviews in Asia Pacific 1.3.5.4 Data for primary interviews in Middle East and Africa 1.4 Information or Data Analysis 1.4.1 Data analysis models 1.5 Market Formulation & Validation 1.6 Model Details 1.6.1 Commodity Flow Analysis (Model 1) 1.6.2 Volume price analysis (Model 2) 1.6.2.1 Approach 2: Volume price analysis 1.7 List of Secondary Sources 1.8 List of Primary Sources 1.9 Objectives 1.9.1 Objective 1 1.9.2 Objective 2 1.9.3 Objective 3 1.9.4 Objective 4 Chapter 2 Executive Summary 2.1 Market Outlook 2.2 Competitive Insights Chapter 3 Orthopedic Software Market Variables, Trends & Scope 3.1 Market Lineage OutlookContinue……….. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email: sales@grandviewresearch.com For More Information: http://www.grandviewresearch.com